Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy
Recruiting · NCT07713537 · Observational (researchers observe without assigning treatment) · Lead sponsor: Hospital Universitari Vall d'Hebron Research Institute
View the official record on ClinicalTrials.gov →Interventions studied
DOAC Level
What this trial is about
Acute ischaemic strokes occur despite the use of direct oral anticoagulants (DOACs). Evidence-based scale is necessary to assess ischemic stroke risk in atrial fibrillation (AF) patients.
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patient over 18 years of age
- History of AD
- Currently on DOACs.
- Capacity to understand the study procedures and provide informed consent.
Exclusion criteria
- Patient with valvular AF (mitral stenosis) or mechanical valve prostheses.
- Unable to complete a follow-up period of at least 3 months from enrollment.
Where it is running
2 locations listed.
- Germans Trias University Hospital - Barcelona, Barcelona, Spain
- Vall d'Hebron University Hospital - Barcelona, Barcelona, Spain